Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 1: Discovery and SAR study of 4-pyrazolylpiperidine side chains.
暂无分享,去创建一个
Karen Holmes | Joseph Kessler | Anthony Carella | D. Hazuda | W. Schleif | E. Emini | J. Lineberger | J. Demartino | K. Chapman | Michael D Miller | Sander G Mills | Martin S Springer | Julie A DeMartino | Janet Lineberger | L. Malkowitz | D. Shen | Dong-Ming Shen | A. Carella | Kevin T Chapman | Lorraine Malkowitz | M. Shu | S. Mills | M. Springer | S. Gould | S. Siciliano | G. Kwei | G. Carver | K. Holmes | R. Danzeisen | J. Kessler | Min Shu | Sandra L Gould | Salvatore J Siciliano | Gloria Y Kwei | Gwen Carver | William A Schleif | Renee Danzeisen | Daria Hazuda | Emilio A Emini | M. Miller | Michael D. Miller | J. DeMartino | Min Shu
[1] J. Haines,et al. CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis , 2000, Immunogenetics.
[2] M. Kavanaugh,et al. A Critical Site in the Core of the CCR5 Chemokine Receptor Required for Binding and Infectivity of Human Immunodeficiency Virus Type 1* , 1999, The Journal of Biological Chemistry.
[3] P D Leeson,et al. 4-Heterocyclylpiperidines as selective high-affinity ligands at the human dopamine D4 receptor. , 1997, Journal of medicinal chemistry.
[4] O. Nishimura,et al. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[5] D. Hazuda,et al. 1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists: modifications of the arylpropylpiperidine side chains. , 2003, Bioorganic & medicinal chemistry letters.
[6] M. Maccoss,et al. 1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 1: discovery of the pyrrolidine scaffold and determination of its stereochemical requirements. , 2001, Bioorganic & medicinal chemistry letters.
[7] Blair,et al. HIV-1 entry - an expanding portal for drug discovery. , 2000, Drug discovery today.
[8] B. Neustadt,et al. Piperazine-based CCR5 antagonists as HIV-1 inhibitors. II. Discovery of 1-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4- methyl-4-[3(S)-methyl-4-[1(S)-[4-(trifluoromethyl)phenyl]ethyl]-1-piperazinyl]- piperidine N1-oxide (Sch-350634), an orally bioavailable, potent CCR5 antagonist. , 2001, Journal of medicinal chemistry.
[9] Richard A Koup,et al. Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection , 1996, Cell.
[10] P. Gray,et al. Co‐receptor use by HIV and inhibition of HIV infection by chemokine receptor ligands , 2000, Immunological reviews.
[11] Michael S. Saag,et al. A Short-Term Clinical Evaluation of L-697,661, a Non-Nucleoside Inhibitor of HIV-1 Reverse Transcriptase , 1993 .
[12] J A Grobler,et al. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells. , 2000, Science.
[13] D. Hazuda,et al. Combinatorial synthesis of CCR5 antagonists. , 2001, Bioorganic & medicinal chemistry letters.
[14] M. Shu,et al. Versatile and efficient solid-phase syntheses of pyrazoles and isoxazoles. , 2000, Organic letters.
[15] M. Springer,et al. The chemokine/chemokine-receptor family: potential and progress for therapeutic intervention. , 2000, Current opinion in chemical biology.
[16] Karen Holmes,et al. 1,3,4 Trisubstituted pyrrolidine CCR5 receptor antagonists bearing 4-aminoheterocycle substituted piperidine side chains. , 2003, Bioorganic & medicinal chemistry letters.
[17] E A Emini,et al. Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 4: synthesis and structure-activity relationships for 1-[N-(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-(4-(N-(alkyl)-N-(benzyloxycarbonyl)amino)piperidin-1-yl)butanes. , 2001, Bioorganic & medicinal chemistry letters.
[18] C. Supuran,et al. Small molecule antagonists of chemokine receptors as emerging anti-HIV agents , 2001 .
[19] D. Hazuda,et al. 1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 4: synthesis of N-1 acidic functionality affording analogues with enhanced antiviral activity against HIV. , 2002, Bioorganic & medicinal chemistry letters.